Abstract
Voclosporin (Lupkynis (TM)), a novel calcineurin inhibitor, is approved in the USA as an add-on to background immunosuppressive therapy in adults with......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
